Supplements
This product scores well on safety due to TMG's established low-risk profile and GRAS status, with no FDA concerns. Effectiveness is moderate as homocysteine reduction is strongly supported (e.g., 6g/day reduced levels 20% in hypoenergetic diet study, PMID:12399266), but product's undisclosed low dose (likely <1g) limits impact compared to clinical 1.5-6g. Quality drags score due to absent dose labeling, no independent testing, and opaque manufacturing—common issues in new brands like Gary Breck
Good option for basic TMG supplementation targeting homocysteine, especially with genetic variants like MTHFR. However, undisclosed dose and lack of testing make it less ideal—opt for verified alternatives. Safe for most at recommended use.